BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 19019615)

  • 1. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry.
    Wang H; Edom RW; Kumar S; Vincent S; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):26-34. PubMed ID: 17442640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems.
    Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma.
    Hsieh Y; Galviz G; Long BJ
    Rapid Commun Mass Spectrom; 2009 May; 23(10):1461-6. PubMed ID: 19350527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive determination of a pharmaceutical compound and its metabolites in human plasma by ultra-high performance liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction.
    Heinig K; Wirz T; Bucheli F; Monin V; Gloge A
    J Pharm Biomed Anal; 2011 Mar; 54(4):742-9. PubMed ID: 21051172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput liquid chromatography with sub-2 microm particles at high pressure and high temperature.
    Nguyen DT; Guillarme D; Heinisch S; Barrioulet MP; Rocca JL; Rudaz S; Veuthey JL
    J Chromatogr A; 2007 Oct; 1167(1):76-84. PubMed ID: 17765255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of four alkaloids in Lindera aggregata by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
    Han Z; Zheng Y; Chen N; Luan L; Zhou C; Gan L; Wu Y
    J Chromatogr A; 2008 Nov; 1212(1-2):76-81. PubMed ID: 18951552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative liquid chromatography/tandem mass spectrometry determination of chloramphenicol residues in food using sub-2 microm particulate high-performance liquid chromatography columns for sensitivity and speed.
    Kaufmann A; Butcher P
    Rapid Commun Mass Spectrom; 2005; 19(24):3694-700. PubMed ID: 16299695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method transfer for fast liquid chromatography in pharmaceutical analysis: application to short columns packed with small particle. Part I: isocratic separation.
    Guillarme D; Nguyen DT; Rudaz S; Veuthey JL
    Eur J Pharm Biopharm; 2007 Jun; 66(3):475-82. PubMed ID: 17267188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry.
    Rainville PD; Wheaton JP; Alden PG; Plumb RS
    Rapid Commun Mass Spectrom; 2008 May; 22(9):1345-50. PubMed ID: 18381621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TopCount coupled to ultra-performance liquid chromatography for the profiling of radiolabeled drug metabolites in complex biological samples.
    Dear GJ; Patel N; Kelly PJ; Webber L; Yung M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 844(1):96-103. PubMed ID: 16931187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study.
    Song W; Pabbisetty D; Groeber EA; Steenwyk RC; Fast DM
    J Pharm Biomed Anal; 2009 Oct; 50(3):491-500. PubMed ID: 19540084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
    Ter Heine R; Hillebrand MJ; Rosing H; van Gorp EC; Mulder JW; Beijnen JH; Huitema AD
    J Pharm Biomed Anal; 2009 Feb; 49(2):451-8. PubMed ID: 19128911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-fast gradient vs. fast isocratic chromatography in bioanalytical quantification by liquid chromatography/tandem mass spectrometry.
    Romanyshyn L; Tiller PR; Alvaro R; Pereira A; Hop CE
    Rapid Commun Mass Spectrom; 2001; 15(5):313-9. PubMed ID: 11241760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supercritical fluid chromatography and high-performance liquid chromatography/tandem mass spectrometric methods for the determination of cytarabine in mouse plasma.
    Hsieh Y; Li F; Duncan CJ
    Anal Chem; 2007 May; 79(10):3856-61. PubMed ID: 17441687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: Matrix effect and chromatographic evaluations.
    De Nardi C; Bonelli F
    Rapid Commun Mass Spectrom; 2006; 20(18):2709-16. PubMed ID: 16921566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of enalapril and enalaprilat in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study.
    Lu S; Jiang K; Qin F; Lu X; Li F
    J Pharm Biomed Anal; 2009 Jan; 49(1):163-7. PubMed ID: 19046843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical comparison of 2.7 microm fused-core silica particles and porous sub-2 microm particles for fast separations in pharmaceutical process development.
    Abrahim A; Al-Sayah M; Skrdla P; Bereznitski Y; Chen Y; Wu N
    J Pharm Biomed Anal; 2010 Jan; 51(1):131-7. PubMed ID: 19758782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
    Mensch J; Noppe M; Adriaensen J; Melis A; Mackie C; Augustijns P; Brewster ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):182-7. PubMed ID: 17095304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.